Kaletra: Therapy With Double Protease Inhibitors

Clinical trial NCT01075191 · COMPLETED

Trial details

NCT number: NCT01075191
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Study type: OBSERVATIONAL

Human Immunodeficiency Virus

Start date: 2004-01-01
Primary completion: 2011-09-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.